Kevin Tan - Chief Financial Officer at Cartesian Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
RNAC on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kevin Tan since 12/17/2023

Holdings reported by Kevin Tan for Cartesian Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Employee Stock Option (right to buy) 340K $269K $0.79 Jan 3, 2022 Direct Common Stock
Common Stock 77K $159K $2.06 Jan 3, 2022 Direct

Transactions reported by Kevin Tan for Cartesian Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.